{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:32:46Z","timestamp":1760059966929,"version":"build-2065373602"},"reference-count":63,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Union Recovery and Resilience Mechanism Plan 4.3.1.r"},{"name":"Riga Stradins University Research Department"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background and Objectives: Accurate noninvasive differentiation between hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) remains a clinical challenge. This study aimed to assess the dignostic performance of apparent diffusion coefficient (ADC) values from diffusion-weighted MRI in distinguishing between HCC and ICC, with histological confirmation as the gold standard. Materials and Methods: A retrospective analysis was performed on 61 patients (41 HCC, 20 ICC) who underwent liver MRI and percutaneous biopsy between 2019 and 2024. ADC values were measured from diffusion-weighted sequences (b-values of 0, 500, and 1000 s\/mm2), and regions of interest were placed over solid tumor areas. Statistical analyses included t-tests, one-way ANOVA, and ROC curve analysis. Results: Mean ADC values did not differ significantly between HCC (1.09 \u00b1 0.19 \u00d7 10\u22123 mm2\/s) and ICC (1.08 \u00b1 0.11 \u00d7 10\u22123 mm2\/s). ROC analysis showed poor discriminative ability (AUC = 0.520; p = 0.806). In HCC, ADC values decreased with lower differentiation grades (p = 0.008, \u03b72 = 0.224). No significant trend was observed in ICC (p = 0.410, \u03b72 = 0.100). Immunohistochemical markers such as CK-7, Glypican 3, and TTF-1 showed significant diagnostic value between tumor subtypes. Conclusions: ADC values have limited utility for distinguishing HCC from ICC but may aid in HCC grading. Immunohistochemistry remains essential for accurate diagnosis, especially in poorly differentiated tumors. Further studies with larger cohorts are recommended to improve noninvasive diagnostic protocols.<\/jats:p>","DOI":"10.3390\/diagnostics15151861","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T10:28:09Z","timestamp":1753352889000},"page":"1861","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of Apparent Diffusion Coefficient Values on Diffusion-Weighted MRI for Differentiating Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2424-443X","authenticated-orcid":false,"given":"Katr\u012bna Marija","family":"Kono\u0161enoka","sequence":"first","affiliation":[{"name":"Department of Radiology, Riga Stradins University, Dzirciema Street, 16, LV-1007 Riga, Latvia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8255-7392","authenticated-orcid":false,"given":"Nauris","family":"Zdanovskis","sequence":"additional","affiliation":[{"name":"Department of Radiology, Riga Stradins University, Dzirciema Street, 16, LV-1007 Riga, Latvia"},{"name":"Department of Interventional Radiology, Riga East University Hospital, Hippocrates St., 2, LV-1038 Riga, Latvia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aina","family":"Kratovska","sequence":"additional","affiliation":[{"name":"Department of Radiology, Riga Stradins University, Dzirciema Street, 16, LV-1007 Riga, Latvia"},{"name":"Department of Interventional Radiology, Riga East University Hospital, Hippocrates St., 2, LV-1038 Riga, Latvia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Art\u016brs","family":"\u0160ilovs","sequence":"additional","affiliation":[{"name":"Department of Radiology, Riga Stradins University, Dzirciema Street, 16, LV-1007 Riga, Latvia"},{"name":"Department of Interventional Radiology, Riga East University Hospital, Hippocrates St., 2, LV-1038 Riga, Latvia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronika","family":"Zaiceva","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Riga East University Hospital, Hippocrates St., 2, LV-1038 Riga, Latvia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"key":"ref_1","unstructured":"Duffell, E., Pisana, A., and Stepien, M. (2025, May 10). Liver Cancer Inequalities in Europe and the Role of Viral Hepatitis. Available online: https:\/\/publications.jrc.ec.europa.eu\/repository\/handle\/JRC138213."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejca.2021.11.023","article-title":"Global, Regional and National Burden of Primary Liver Cancer by Subtype","volume":"161","author":"Rumgay","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.jhep.2021.01.035","article-title":"Combined Hepatocellular-Cholangiocarcinoma: An Update","volume":"74","author":"Calderaro","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Eschrich, J., Kobus, Z., Geisel, D., Halskov, S., Ro\u00dfner, F., Roderburg, C., Mohr, R., and Tacke, F. (2023). The Diagnostic Approach Towards Combined Hepatocellular-Cholangiocarcinoma-State of the Art and Future Perspectives. Cancers, 15.","DOI":"10.3390\/cancers15010301"},{"key":"ref_5","unstructured":"Saxena, R. (2018). 33-Hepatocellular Carcinoma. Practical Hepatic Pathology: A Diagnostic Approach, Elsevier. [2nd ed.]. Pattern Recognition."},{"key":"ref_6","unstructured":"(2025, May 15). Histopathological Variants of Hepatocellular Carcinomas: An Update According to the 5th Edition of the WHO Classification of Digestive System Tumors. Available online: https:\/\/www.e-jlc.org\/journal\/view.php?doi=10.17998\/jlc.20.1.17."},{"key":"ref_7","unstructured":"(2025, May 15). The Liver and Spleen\u2014ClinicalKey. Available online: https:\/\/www-clinicalkey-com.db.rsu.lv\/#!\/content\/3-s2.0-B9780702075247000239?scrollTo=%23hl0001395."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC Strategy for Prognosis Prediction and Treatment Recommendation: The 2022 Update","volume":"76","author":"Reig","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1007\/s00261-014-0300-0","article-title":"Primary Biliary Tract Malignancies: MRI Spectrum and Mimics with Histopathological Correlation","volume":"40","author":"Mittal","year":"2015","journal-title":"Abdom. Imaging"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO Classification of Tumours of the Digestive System","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jhep.2021.12.010","article-title":"Cholangiocarcinoma Landscape in Europe: Diagnostic, Prognostic and Therapeutic Insights from the ENSCCA Registry","volume":"76","author":"Lamarca","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jhep.2023.03.010","article-title":"EASL-ILCA Clinical Practice Guidelines on the Management of Intrahepatic Cholangiocarcinoma","volume":"79","author":"Alvaro","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1177\/02841851221113265","article-title":"Optimizing CT and MRI Criteria for Differentiating Intrahepatic Mass-Forming Cholangiocarcinoma and Hepatocellular Carcinoma","volume":"64","author":"Wu","year":"2023","journal-title":"Acta Radiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1148\/radiol.2016160639","article-title":"Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis: Differentiation from Hepatocellular Carcinoma by Using Gadoxetic Acid\u2013Enhanced MR Imaging and Dynamic CT","volume":"282","author":"Choi","year":"2017","journal-title":"Radiology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1148\/radiol.2016151205","article-title":"Small Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in Cirrhotic Livers May Share Similar Enhancement Patterns at Multiphase Dynamic MR Imaging","volume":"281","author":"Huang","year":"2016","journal-title":"Radiology"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Li, R., Cai, P., Ma, K., Ding, S.-Y., Guo, D.-Y., and Yan, X.-C. (2016). Dynamic Enhancement Patterns of Intrahepatic Cholangiocarcinoma in Cirrhosis on Contrast-Enhanced Computed Tomography: Risk of Misdiagnosis as Hepatocellular Carcinoma. Sci. Rep., 6.","DOI":"10.1038\/srep26772"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Messina, C., Bignone, R., Bruno, A., Bruno, A., Bruno, F., Calandri, M., Caruso, D., Coppolino, P., Robertis, R.D., and Gentili, F. (2020). Diffusion-Weighted Imaging in Oncology: An Update. Cancers, 12.","DOI":"10.3390\/cancers12061493"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/jmri.22786","article-title":"Oncologic Applications of Diffusion-Weighted MRI in the Body","volume":"35","author":"Bonekamp","year":"2012","journal-title":"J. Magn. Reson. Imaging"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1148\/rg.316115515","article-title":"Principles and Applications of Diffusion-Weighted Imaging in Cancer Detection, Staging, and Treatment Follow-Up","volume":"31","author":"Malayeri","year":"2011","journal-title":"Radiographics"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Peng, J., Zheng, J., Yang, C., Wang, R., Zhou, Y., Tao, Y.-Y., Gong, X.-Q., Wang, W.-C., Zhang, X.-M., and Yang, L. (2020). Intravoxel Incoherent Motion Diffusion-Weighted Imaging to Differentiate Hepatocellular Carcinoma from Intrahepatic Cholangiocarcinoma. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-64804-9"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.1007\/s00330-023-09788-6","article-title":"Apparent Diffusion Coefficient Correlates with Different Histopathological Features in Several Intrahepatic Tumors","volume":"33","author":"Surov","year":"2023","journal-title":"Eur. Radiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/jmri.26253","article-title":"Volumetric Apparent Diffusion Coefficient Histogram Analysis in Differentiating Intrahepatic Mass-Forming Cholangiocarcinoma from Hepatocellular Carcinoma","volume":"49","author":"Zou","year":"2019","journal-title":"J. Magn. Reson. Imaging"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"7975","DOI":"10.18632\/oncotarget.23807","article-title":"Intrahepatic Cholangiocarcinoma in the Setting of HBV-Related Cirrhosis: Differentiation with Hepatocellular Carcinoma by Using Intravoxel Incoherent Motion Diffusion-Weighted MR Imaging","volume":"9","author":"Wei","year":"2018","journal-title":"Oncotarget"},{"key":"ref_24","first-page":"e947428","article-title":"Editorial: The 2024 Revision of the Declaration of Helsinki and Its Continued Role as a Code of Ethics to Guide Medical Research","volume":"30","author":"Parums","year":"2024","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"ref_25","unstructured":"(IBM SPSS Statistics for Windows, 2022). IBM SPSS Statistics for Windows, Version 29.0."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jhep.2015.11.016","article-title":"Insights into the Diagnosis of Hepatocellular Carcinomas with Hepatobiliary MRI","volume":"64","author":"Vilgrain","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1007\/s00330-020-06687-y","article-title":"Gadoxetic Acid-Enhanced MR Imaging for Hepatocellular Carcinoma: Molecular and Genetic Background","volume":"30","author":"Kitao","year":"2020","journal-title":"Eur. Radiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/hep.32397","article-title":"Molecular and Radiopathologic Spectrum Between HCC and Intrahepatic Cholangiocarcinoma","volume":"77","author":"Jeon","year":"2023","journal-title":"Hepatology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00261-017-1261-x","article-title":"Imaging Features of Hepatocellular Carcinoma Compared to Intrahepatic Cholangiocarcinoma and Combined Tumor on MRI Using Liver Imaging and Data System (LI-RADS) Version 2014","volume":"43","author":"Horvat","year":"2018","journal-title":"Abdom. Radiol."},{"key":"ref_30","unstructured":"(2025, May 15). Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients|Radiology. Available online: https:\/\/pubs.rsna.org\/doi\/abs\/10.1148\/radiol.2018181494?journalCode=radiology."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e220646","DOI":"10.1148\/radiol.220646","article-title":"Percentages of Hepatocellular Carcinoma in LI-RADS Categories with CT and MRI: A Systematic Review and Meta-Analysis","volume":"307","author":"Lee","year":"2023","journal-title":"Radiology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1148\/radiol.2018181290","article-title":"LI-RADS Classification and Prognosis of Primary Liver Cancers at Gadoxetic Acid-Enhanced MRI","volume":"290","author":"Choi","year":"2019","journal-title":"Radiology"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Zhou, Y., Yang, G., Gong, X.-Q., Tao, Y.-Y., Wang, R., Zheng, J., Yang, C., Peng, J., Yang, L., and Li, J.-D. (2021). A Study of the Correlations Between IVIM-DWI Parameters and the Histologic Differentiation of Hepatocellular Carcinoma. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-89784-2"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Park, I.K., Yu, J.-S., Cho, E.-S., Kim, J.H., and Chung, J.-J. (2018). Apparent Diffusion Coefficient of Hepatocellular Carcinoma on Diffusion-Weighted Imaging: Histopathologic Tumor Grade versus Arterial Vascularity during Dynamic Magnetic Resonance Imaging. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0197070"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/jmri.26963","article-title":"Diagnostic Accuracy of Quantitative Diffusion Parameters in the Pathological Grading of Hepatocellular Carcinoma: A Meta-Analysis","volume":"51","author":"Yang","year":"2020","journal-title":"J. Magn. Reson. Imaging"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"20210059","DOI":"10.1259\/bjr.20210059","article-title":"Diagnostic Accuracy of Apparent Diffusion Coefficient (ADC) Value in Differentiating Malignant from Benign Solid Liver Lesions: A Systematic Review and Meta-Analysis","volume":"94","author":"Nalaini","year":"2021","journal-title":"Br. J. Radiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.crad.2018.12.016","article-title":"Differentiating Between Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma Using Contrast-Enhanced MRI Features: A Systematic Review and Meta-Analysis","volume":"74","author":"You","year":"2019","journal-title":"Clin. Radiol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Zhang, S., Huo, L., Feng, Y., Zhang, J., Wu, Y., Liu, Y., Lu, L., Jia, N., and Liu, W. (2022). Preoperative Differentiation of Hepatocellular Carcinoma with Peripheral Rim-like Enhancement from Intrahepatic Mass-Forming Cholangiocarcinoma on Contrast-Enhanced MRI. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.986713"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejrad.2017.04.008","article-title":"Differentiation Between Cholangiocarcinoma and Hepatocellular Carcinoma with Target Sign on Diffusion-Weighted Imaging and Hepatobiliary Phase Gadoxetic Acid-Enhanced MR Imaging: Classification Tree Analysis Applying Capsule and Septum","volume":"92","author":"Min","year":"2017","journal-title":"Eur. J. Radiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1007\/s00330-017-5156-6","article-title":"Prediction of the Histopathologic Findings of Intrahepatic Cholangiocarcinoma: Qualitative and Quantitative Assessment of Diffusion-Weighted Imaging","volume":"28","author":"Lewis","year":"2018","journal-title":"Eur. Radiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1148\/radiol.2016151781","article-title":"Mass-Forming Intrahepatic Cholangiocarcinoma: Diffusion-Weighted Imaging as a Preoperative Prognostic Marker","volume":"281","author":"Lee","year":"2016","journal-title":"Radiology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1148\/radiol.12111530","article-title":"Diffusion-Weighted MR Imaging for the Regional Characterization of Liver Tumors","volume":"264","author":"Wagner","year":"2012","journal-title":"Radiology"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Kova\u010d, J.D., Dakovi\u0107, M., Jankovi\u0107, A., Mitrovi\u0107, M., Dugali\u0107, V., Galun, D., \u0110uri\u0107-Stefanovi\u0107, A., and Ma\u0161ulovi\u0107, D. (2021). The Role of Quantitative Diffusion-Weighted Imaging in Characterization of Hypovascular Liver Lesions: A Prospective Comparison of Intravoxel Incoherent Motion Derived Parameters and Apparent Diffusion Coefficient. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0247301"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/0284185117706608","article-title":"Diffusion Kurtosis Imaging of the Liver at 3 Tesla: In Vivo Comparison to Standard Diffusion-Weighted Imaging","volume":"59","author":"Budjan","year":"2018","journal-title":"Acta Radiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3892\/ol.2022.13523","article-title":"Quantitative Analysis for Detection and Grading of Hepatocellular Carcinoma: Comparison of Diffusion Kurtosis Imaging, Intravoxel Incoherent Motion and Conventional Diffusion-Weighted Imaging","volume":"24","author":"Li","year":"2022","journal-title":"Oncol. Lett."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1007\/s00261-021-03240-3","article-title":"Whole Tumor Volumetric ADC Analysis: Relationships with Histopathological Differentiation of Hepatocellular Carcinoma","volume":"46","author":"Piskin","year":"2021","journal-title":"Abdom. Radiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1007\/s00261-023-04171-x","article-title":"Mean ADC Values and Arterial Phase Hyperintensity Discriminate Small (\u2264\u20093 cm) Well-Differentiated Hepatocellular Carcinoma from Dysplastic Nodule","volume":"49","author":"Zong","year":"2024","journal-title":"Abdom. Radiol. N. Y."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"110356","DOI":"10.1016\/j.mri.2025.110356","article-title":"Association Between Radiomics of Diffusion-Weighted Imaging and Histopathology in Hepatocellular Carcinoma. A Preliminary Investigation","volume":"118","author":"Meyer","year":"2025","journal-title":"Magn. Reson. Imaging"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jhep.2019.12.001","article-title":"Non-Enhanced Magnetic Resonance Imaging as a Surveillance Tool for Hepatocellular Carcinoma: Comparison with Ultrasound","volume":"72","author":"Park","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/jhbp.732","article-title":"Prognostic Prediction of Apparent Diffusion Coefficient Obtained by Diffusion-Weighted MRI in Mass-Forming Intrahepatic Cholangiocarcinoma","volume":"27","author":"Yamada","year":"2020","journal-title":"J. Hepato-Biliary-Pancreat. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD Practice Guidance on Prevention, Diagnosis, and Treatment of Hepatocellular Carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"5812","DOI":"10.7150\/jca.46927","article-title":"Differences in Tumour Characteristics of Hepatocellular Carcinoma Between Patients with and Without Cirrhosis: A Population-Based Study","volume":"11","author":"Yan","year":"2020","journal-title":"J. Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/dc.24759","article-title":"The Strength of Cytomorphology and Efficacy of Immuno-Cytochemistry in Distinguishing Hepatocellular Carcinoma from Its Mimics on Fine-Needle Aspiration Cytology","volume":"49","author":"Chikhale","year":"2021","journal-title":"Diagn. Cytopathol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e318158142f","article-title":"Distinction of Hepatocellular Carcinoma from Benign Hepatic Mimickers Using Glypican-3 and CD34 Immunohistochemistry","volume":"32","author":"Coston","year":"2008","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_55","unstructured":"(2025, May 16). Diagnostic Value of Immunohistochemical Staining of GP73, GPC3, DCP, CD34, CD31, and Reticulin Staining in Hepatocellular Carcinoma\u2014PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/23686365\/."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Choi, J.H., and Thung, S.N. (2024). Recent Advances in Pathology of Intrahepatic Cholangiocarcinoma. Cancers, 16.","DOI":"10.20944\/preprints202403.0198.v1"},{"key":"ref_57","first-page":"1669","article-title":"Clinical Relevance of Biomarkers in Cholangiocarcinoma: Critical Revision and Future Directions","volume":"71","author":"Macias","year":"2022","journal-title":"Gut"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"101951","DOI":"10.1016\/j.mcp.2024.101951","article-title":"Intrahepatic Cholangiocarcinoma Biomarkers: Towards Early Detection and Personalized Pharmacological Treatments","volume":"73","author":"Capuozzo","year":"2024","journal-title":"Mol. Cell. Probes"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/his.13884","article-title":"Keratin 19-Expressing Hepatocellular Carcinoma and Small-Duct Type Intrahepatic Cholangiocarcinoma Show a Similar Postoperative Clinical Course but Have Distinct Genetic Features","volume":"75","author":"Akita","year":"2019","journal-title":"Histopathology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.humpath.2021.05.012","article-title":"Diagnostic and Prognostic Impact of Cytokeratin 19 Expression Analysis in Human Tumors: A Tissue Microarray Study of 13,172 Tumors","volume":"115","author":"Menz","year":"2021","journal-title":"Hum. Pathol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.7150\/jca.44697","article-title":"CK19-Positive Hepatocellular Carcinoma Is a Characteristic Subtype","volume":"11","author":"Zhuo","year":"2020","journal-title":"J. Cancer"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/PAI.0000000000000840","article-title":"Hepatocellular Carcinoma Score and Subclassification into Aggressive Subtypes Using Immunohistochemical Expression of P53, \u03b2-Catenin, CD133, and Ki-67","volume":"29","author":"Abdou","year":"2021","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/02841851241310394","article-title":"Multiparametric Magnetic Resonance Imaging-Derived Radiomics for the Prediction of Ki67 Expression in Intrahepatic Cholangiocarcinoma","volume":"66","author":"Wang","year":"2025","journal-title":"Acta Radiol."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/15\/1861\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:15:08Z","timestamp":1760033708000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/15\/1861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":63,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["diagnostics15151861"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics15151861","relation":{},"ISSN":["2075-4418"],"issn-type":[{"type":"electronic","value":"2075-4418"}],"subject":[],"published":{"date-parts":[[2025,7,24]]}}}